A new trading day began on Tuesday, with Terns Pharmaceuticals Inc (NASDAQ: TERN) stock price up 1.55% from the previous day of trading, before settling in for the closing price of $5.79. TERN’s price has ranged from $3.68 to $11.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. Meanwhile, its annual earnings per share averaged 4.51%. With a float of $62.16 million, this company’s outstanding shares have now reached $64.58 million.
The firm has a total of 66 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 26.82%, while institutional ownership is 71.56%. The most recent insider transaction that took place on Sep 12 ’24, was worth 4,999,995. In this transaction Director of this company bought 476,190 shares at a rate of $10.50, taking the stock ownership to the 476,190 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Chief Financial Officer sold 10,000 for $11.00, making the entire transaction worth $110,000. This insider now owns 91,940 shares in total.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.29 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.51% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Here are Terns Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 32.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.37 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Analysing the last 5-days average volume posted by the [Terns Pharmaceuticals Inc, TERN], we can find that recorded value of 1.53 million was better than the volume posted last year of 1.29 million. As of the previous 9 days, the stock’s Stochastic %D was 20.22%. Additionally, its Average True Range was 0.43.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 7.07%, which indicates a significant decrease from 19.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.09% in the past 14 days, which was lower than the 79.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.47, while its 200-day Moving Average is $7.13. Now, the first resistance to watch is $6.03. This is followed by the second major resistance level at $6.17. The third major resistance level sits at $6.32. If the price goes on to break the first support level at $5.74, it is likely to go to the next support level at $5.59. Now, if the price goes above the second support level, the third support stands at $5.45.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
With a market capitalization of 499.44 million, the company has a total of 84,939K Shares Outstanding. Currently, annual sales are 0 K while annual income is -90,210 K. The company’s previous quarter sales were 0 K while its latest quarter income was -21,950 K.
